<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="discussion" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Lancet</journal-id><journal-id journal-id-type="iso-abbrev">Lancet</journal-id><journal-id journal-id-type="pmc-domain-id">3815</journal-id><journal-id journal-id-type="pmc-domain">pheelsevier</journal-id><journal-title-group><journal-title>Lancet (London, England)</journal-title></journal-title-group><issn pub-type="ppub">0140-6736</issn><issn pub-type="epub">1474-547X</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Elsevier - PMC COVID-19 Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7906746</article-id><article-id pub-id-type="pmcid-ver">PMC7906746.1</article-id><article-id pub-id-type="pmcaid">7906746</article-id><article-id pub-id-type="pmcaiid">7906746</article-id><article-id pub-id-type="pmid">33515491</article-id><article-id pub-id-type="doi">10.1016/S0140-6736(21)00183-5</article-id><article-id pub-id-type="pii">S0140-6736(21)00183-5</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Comment</subject></subj-group></article-categories><title-group><article-title>Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence</article-title></title-group><contrib-group><contrib contrib-type="author" id="au10"><name name-style="western"><surname>Sabino</surname><given-names initials="EC">Ester C</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au20"><name name-style="western"><surname>Buss</surname><given-names initials="LF">Lewis F</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au30"><name name-style="western"><surname>Carvalho</surname><given-names initials="MPS">Maria P S</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au40"><name name-style="western"><surname>Prete</surname><given-names initials="CA">Carlos A</given-names><suffix>Jr</suffix></name><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au50"><name name-style="western"><surname>Crispim</surname><given-names initials="MAE">Myuki A E</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au60"><name name-style="western"><surname>Fraiji</surname><given-names initials="NA">Nelson A</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au70"><name name-style="western"><surname>Pereira</surname><given-names initials="RHM">Rafael H M</given-names></name><xref rid="aff4" ref-type="aff">d</xref></contrib><contrib contrib-type="author" id="au80"><name name-style="western"><surname>Parag</surname><given-names initials="KV">Kris V</given-names></name><xref rid="aff5" ref-type="aff">e</xref></contrib><contrib contrib-type="author" id="au90"><name name-style="western"><surname>da Silva Peixoto</surname><given-names initials="P">Pedro</given-names></name><xref rid="aff6" ref-type="aff">f</xref></contrib><contrib contrib-type="author" id="au100"><name name-style="western"><surname>Kraemer</surname><given-names initials="MUG">Moritz U G</given-names></name><xref rid="aff7" ref-type="aff">g</xref></contrib><contrib contrib-type="author" id="au110"><name name-style="western"><surname>Oikawa</surname><given-names initials="MK">Marcio K</given-names></name><xref rid="aff8" ref-type="aff">h</xref></contrib><contrib contrib-type="author" id="au120"><name name-style="western"><surname>Salomon</surname><given-names initials="T">Tassila</given-names></name><xref rid="aff9" ref-type="aff">i</xref><xref rid="aff10" ref-type="aff">j</xref></contrib><contrib contrib-type="author" id="au130"><name name-style="western"><surname>Cucunuba</surname><given-names initials="ZM">Zulma M</given-names></name><xref rid="aff5" ref-type="aff">e</xref></contrib><contrib contrib-type="author" id="au140"><name name-style="western"><surname>Castro</surname><given-names initials="MC">M&#225;rcia C</given-names></name><xref rid="aff11" ref-type="aff">k</xref></contrib><contrib contrib-type="author" id="au150"><name name-style="western"><surname>de Souza Santos</surname><given-names initials="AA">Andreza Aruska</given-names></name><xref rid="aff12" ref-type="aff">l</xref></contrib><contrib contrib-type="author" id="au160"><name name-style="western"><surname>Nascimento</surname><given-names initials="VH">V&#237;tor H</given-names></name><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au170"><name name-style="western"><surname>Pereira</surname><given-names initials="HS">Henrique S</given-names></name><xref rid="aff13" ref-type="aff">m</xref></contrib><contrib contrib-type="author" id="au180"><name name-style="western"><surname>Ferguson</surname><given-names initials="NM">Neil M</given-names></name><xref rid="aff5" ref-type="aff">e</xref></contrib><contrib contrib-type="author" id="au190"><name name-style="western"><surname>Pybus</surname><given-names initials="OG">Oliver G</given-names></name><xref rid="aff7" ref-type="aff">g</xref></contrib><contrib contrib-type="author" id="au200"><name name-style="western"><surname>Kucharski</surname><given-names initials="A">Adam</given-names></name><xref rid="aff14" ref-type="aff">n</xref></contrib><contrib contrib-type="author" id="au210"><name name-style="western"><surname>Busch</surname><given-names initials="MP">Michael P</given-names></name><xref rid="aff15" ref-type="aff">o</xref><xref rid="aff16" ref-type="aff">p</xref></contrib><contrib contrib-type="author" id="au220"><name name-style="western"><surname>Dye</surname><given-names initials="C">Christopher</given-names></name><xref rid="aff7" ref-type="aff">g</xref></contrib><contrib contrib-type="author" id="au230"><name name-style="western"><surname>Faria</surname><given-names initials="NR">Nuno R</given-names></name><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff5" ref-type="aff">e</xref><xref rid="aff7" ref-type="aff">g</xref></contrib><aff id="aff1"><label>a</label>Departamento de Molestias Infecciosas e Parasitarias and Instituto de Medicina Tropical da Faculdade de Medicina da Universidade de S&#227;o Paulo, S&#227;o Paulo, SP 05403&#8211;000, Brazil</aff><aff id="aff2"><label>b</label>Funda&#231;&#227;o Hospitalar de Hematologia e Hemoterapia do Amazonas, Manaus, Brazil</aff><aff id="aff3"><label>c</label>Departamento de Engenharia de Sistemas Eletr&#244;nicos, Escola Polit&#233;cnica da Universidade de S&#227;o Paulo, S&#227;o Paulo, Brazil</aff><aff id="aff4"><label>d</label>Institute for Applied Economic Research&#8211;Ipea, Bras&#237;lia, Brazil</aff><aff id="aff5"><label>e</label>MRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, London, UK</aff><aff id="aff6"><label>f</label>Institute of Mathematics and Statistics, University of S&#227;o Paulo, S&#227;o Paulo, Brazil</aff><aff id="aff7"><label>g</label>Department of Zoology, University of Oxford, Oxford, UK</aff><aff id="aff8"><label>h</label>Center of Mathematics, Computing and Cognition&#8211;Universidade Federal do ABC, S&#227;o Paulo, Brazil</aff><aff id="aff9"><label>i</label>Funda&#231;&#227;o Hemominas&#8211;Funda&#231;&#227;o Centro de Hematologia e Hemoterapia de Minas Gerais, Belo Horizonte, Brazil</aff><aff id="aff10"><label>j</label>Faculdade Ci&#234;ncias M&#233;dicas de Minas Gerais, Belo Horizonte, Brazil</aff><aff id="aff11"><label>k</label>Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA</aff><aff id="aff12"><label>l</label>Oxford School of Global and Area Studies, Latin American Centre, University of Oxford, Oxford, UK</aff><aff id="aff13"><label>m</label>Centro de Ci&#234;ncias Ambientais, Universidade Federal do Amazonas, Manaus, Brazil</aff><aff id="aff14"><label>n</label>Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene &amp; Tropical Medicine, London, UK</aff><aff id="aff15"><label>o</label>Vitalant Research Institute, San Francisco, CA, USA</aff><aff id="aff16"><label>p</label>University of California, San Francisco, CA, USA</aff></contrib-group><pub-date pub-type="ppub" iso-8601-date="2021-02-12"><season>6-12 February</season><year>2021</year></pub-date><pub-date pub-type="epub"><day>27</day><month>1</month><year>2021</year></pub-date><volume>397</volume><issue>10273</issue><issue-id pub-id-type="pmc-issue-id">376090</issue-id><fpage>452</fpage><lpage>455</lpage><pub-history><event event-type="pmc-release"><date><day>27</day><month>01</month><year>2021</year></date></event><event event-type="pmc-live"><date><day>26</day><month>02</month><year>2021</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2022-12-16 07:10:15.510"><day>16</day><month>12</month><year>2022</year></date></event></pub-history><permissions><copyright-statement>&#169; 2021 Elsevier Ltd. All rights reserved.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Elsevier Ltd</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p id="para10">After initially containing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many European and Asian countries had a resurgence of COVID-19 consistent with a large proportion of the population remaining susceptible to the virus after the first epidemic wave.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> By contrast, in Manaus, Brazil, a study of blood donors indicated that 76% (95% CI 67&#8211;98) of the population had been infected with SARS-CoV-2 by October, 2020.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> High attack rates of SARS-CoV-2 were also estimated in population-based samples from other locations in the Amazon Basin&#8212;eg, Iquitos, Peru 70% (67&#8211;73).<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> The estimated SARS-CoV-2 attack rate in Manaus would be above the theoretical herd immunity threshold (67%), given a basic case reproduction number (R<sub>0</sub>) of 3.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref>
</p><p id="para20">In this context, the abrupt increase in the number of COVID-19 hospital admissions in Manaus during January, 2021 (3431 in Jan 1&#8211;19, 2021, <italic toggle="yes">vs</italic> 552 in Dec 1&#8211;19, 2020) is unexpected and of concern (<xref rid="fig1" ref-type="fig">figure</xref>
).<xref rid="bib5" ref-type="bibr">5</xref>, <xref rid="bib6" ref-type="bibr">6</xref>, <xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib8" ref-type="bibr">8</xref>, <xref rid="bib9" ref-type="bibr">9</xref>, <xref rid="bib10" ref-type="bibr">10</xref> After a large epidemic that peaked in late April, 2020, COVID-19 hospitalisations in Manaus remained stable and fairly low for 7 months from May to November, despite the relaxation of COVID-19 control measures during that period (<xref rid="fig1" ref-type="fig">figure</xref>).<fig id="fig1" position="float" orientation="portrait"><label>Figure</label><caption><p>COVID-19 hospitalisations, excess deaths, and R<sub>t</sub> in Manaus, Brazil, 2020&#8211;21</p><p>(A) Dark lines are the 7-day rolling averages and lighter lines are the daily time series of COVID-19 hospitalisations and excess deaths. Hospitalisation data are from the Funda&#231;&#227;o de Vigil&#226;ncia em Sa&#250;de do Amazonas.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> Total all-cause deaths for 2020&#8211;21 were reported initially by the Prefeitura de Manaus<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> and subsequently in the daily COVID-19 bulletin of the Funda&#231;&#227;o de Vigil&#226;ncia em Sa&#250;de do Amazonas.<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> All-cause deaths from 2019 were from Arpen/AM (Associa&#231;&#227;o dos Registradores Civis das Pessoas Naturais do Amazonas).<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> The compiled excess death data are from Bruce Nelson from the Instituto Nacional de Pesquisas da Amaz&#244;nia.<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref> (B) <italic toggle="yes">R</italic><sub>t</sub> was calculated using the time series of COVID-19 hospitalisations after removal of the past 14 days to account for delays in notification. <italic toggle="yes">R</italic><sub>t</sub> was calculated using the EpiFilter method.<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> Lines are median <italic toggle="yes">R</italic><sub>t</sub> estimates; shaded areas are the 95% CIs. <italic toggle="yes">R</italic><sub>t</sub>=Effective reproduction number. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr1_lrg.jpg"/></fig></p><p id="para30">There are at least four non-mutually exclusive possible explanations for the resurgence of COVID-19 in Manaus. First, the SARS-CoV-2 attack rate could have been overestimated during the first wave, and the population remained below the herd immunity threshold until the beginning of December, 2020. In this scenario, the resurgence could be explained by greater mixing of infected and susceptible individuals during December. The 76% estimate of past infection<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> might have been biased upwards due to adjustments to the observed 52&#183;5% (95% CI 47&#183;6&#8211;57&#183;5) seroprevalence in June, 2020, to account for antibody waning. However, even this lower bound should confer important population immunity to avoid a larger outbreak. Furthermore, comparisons of blood donors with census data showed no major difference in a range of demographic variables,<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> and the mandatory exclusion of donors with symptoms of COVID-19 is expected to underestimate the true population exposure to the virus. Reanalysis and model comparison<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> by independent groups will help inform the best-fitting models for antibody waning and the representativeness of blood donors.</p><p id="para40">Second, immunity against infection might have already begun to wane by December, 2020, because of a general decrease in immune protection against SARS-CoV-2 after a first exposure. Waning of anti-nucleocapsid IgG antibody titres observed in blood donors<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> might reflect a loss of immune protection, although immunity to SARS-CoV-2 depends on a combination of B-cell and T-cell responses.<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> A study of UK health-care workers<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> showed that reinfection with SARS-CoV-2 is uncommon up to 6 months after the primary infection. However, most of the SARS-CoV-2 infections in Manaus occurred 7&#8211;8 months before the resurgence in January, 2021; this is longer than the period covered by the UK study,<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> but nonetheless suggests that waning immunity alone is unlikely to fully explain the recent resurgence. Moreover, population mobility in Manaus decreased from mid-November, 2020, with a sharp reduction in late December, 2020,<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> suggesting that behavioural change does not account for the resurgence of hospitalisations.</p><p id="para50">Third, SARS-CoV-2 lineages might evade immunity generated in response to previous infection.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> Three recently detected SARS-CoV-2 lineages (B.1.1.7, B.1.351, and P.1), are unusually divergent and each possesses a unique constellation of mutations of potential biological importance.<xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib17" ref-type="bibr">17</xref>, <xref rid="bib18" ref-type="bibr">18</xref> Of these, two are circulating in Brazil (B.1.1.7 and P.1) and one (P.1) was detected in Manaus on Jan 12, 2021.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> One case of SARS-CoV-2 reinfection has been associated with the P.1 lineage in Manaus<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> that accrued ten unique spike protein mutations, including E484K and N501K.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> Moreover, the newly classified P.2 lineage (sublineage of B.1.128 that independently accrued the spike E484K mutation) has now been detected in several locations in Brazil, including Manaus.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> P.2 variants with the E484K mutation have been detected in two people who have been reinfected with SARS-CoV-2 in Brazil,<xref rid="bib21" ref-type="bibr">21</xref>, <xref rid="bib22" ref-type="bibr">22</xref> and there is in-vitro evidence that the presence of the E484K mutation reduces neutralisation by polyclonal antibodies in convalescent sera.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref>
</p><p id="para60">Fourth, SARS-CoV-2 lineages circulating in the second wave might have higher inherent transmissibility than pre-existing lineages circulating in Manaus. The P.1 lineage was first discovered in Manaus.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> In a preliminary study, this lineage reached a high frequency (42%, 13 of 31) among genome samples obtained from COVID-19 cases in December, 2020, but was absent in 26 samples collected in Manaus between March and November, 2020.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> Thus far, little is known about the transmissibility of the P.1 lineage, but it shares several independently acquired mutations with the B.1.1.7 (N501Y) and the B.1.325 (K417N/T, E484K, N501Y) lineages circulating in the UK and South Africa, which seem to have increased transmissibility.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> Contact tracing and outbreak investigation data are needed to better understand relative transmissibility of this lineage.</p><p id="para70">The new SARS-CoV-2 lineages may drive a resurgence of cases in the places where they circulate if they have increased transmissibility compared with pre-existing circulating lineages and if they are associated with antigenic escape. For this reason, the genetic, immunological, clinical, and epidemiological characteristics of these SARS-CoV-2 variants need to be quickly investigated. Conversely, if resurgence in Manaus is due to waning of protective immunity, then similar resurgence scenarios should be expected in other locations. Sustained serological and genomic surveillance in Manaus and elsewhere is a priority, with simultaneous monitoring for SARS-CoV-2 reinfections and implementation of non-pharmaceutical interventions. Determining the efficacy of existing COVID-19 vaccines against variants in the P.1 lineage and other lineages with potential immune escape variants is also crucial. Genotyping viruses from COVID-19 patients who were not protected by vaccination in clinical trials would help us to understand if there are lineage-specific frequencies underlying reinfection. The protocols and findings of such studies should be coordinated and rapidly shared wherever such variants emerge and spread.</p><p id="para80">Since rapid data sharing is the basis for the development and implementation of actionable disease control measures during public health emergencies, we are openly sharing in real-time monthly curated serosurvey data from blood donors through the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://github.com/CADDE-CENTRE" id="interrefs10">Brazil&#8211;UK Centre for Arbovirus Discovery, Diagnosis, Genomics and Epidemiology (CADDE) Centre GitHub website</ext-link> and will continue to share genetic sequence data and results from Manaus through openly accessible data platforms such as <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.gisaid.org/" id="interrefs20">GISAID</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://virological.org" id="interrefs30">Virological</ext-link>.</p></body><back><ref-list id="bibl10"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sbref10"><person-group person-group-type="author"><name name-style="western"><surname>Lucy</surname><given-names>CO</given-names></name><name name-style="western"><surname>Verity</surname><given-names>R</given-names></name><name name-style="western"><surname>Watson</surname><given-names>OJ</given-names></name><etal/></person-group><article-title>Have deaths from COVID-19 in Europe plateaued due to herd immunity?</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>e110</fpage><lpage>e111</lpage><pub-id pub-id-type="pmid">32534627</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(20)31357-X</pub-id><pub-id pub-id-type="pmcid">PMC7289569</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sbref20"><person-group person-group-type="author"><name name-style="western"><surname>Buss</surname><given-names>LF</given-names></name><name name-style="western"><surname>Prete</surname><given-names>CA</given-names></name><name name-style="western"><surname>Abrahim</surname><given-names>CMM</given-names></name><etal/></person-group><article-title>Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic</article-title><source>Science</source><volume>371</volume><year>2020</year><fpage>288</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">33293339</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.abe9728</pub-id><pub-id pub-id-type="pmcid">PMC7857406</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sbref30"><person-group person-group-type="author"><name name-style="western"><surname>&#193;lvarez-Antonio</surname><given-names>C</given-names></name><name name-style="western"><surname>Meza-S&#225;nchez</surname><given-names>G</given-names></name><name name-style="western"><surname>Calampa</surname><given-names>C</given-names></name><etal/></person-group><article-title>Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru</article-title><source>MedRxiv</source><year>2021</year><comment>published online 20.</comment><pub-id pub-id-type="doi">10.1101/2021.01.17.21249913</pub-id><comment>(preprint)</comment><pub-id pub-id-type="pmcid">PMC8133769</pub-id><pub-id pub-id-type="pmid">34022148</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sbref40"><person-group person-group-type="author"><name name-style="western"><surname>Fontanet</surname><given-names>A</given-names></name><name name-style="western"><surname>Cauchemez</surname><given-names>S</given-names></name></person-group><article-title>COVID-19 herd immunity: where are we?</article-title><source>Nat Rev Immunol</source><volume>20</volume><year>2020</year><fpage>583</fpage><lpage>584</lpage><pub-id pub-id-type="pmid">32908300</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41577-020-00451-5</pub-id><pub-id pub-id-type="pmcid">PMC7480627</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="other" id="sbref50"><person-group person-group-type="author"><collab>Funda&#231;&#227;o de Vigil&#226;ncia em Sa&#250;de do Amazonas</collab></person-group><article-title>COVID-19 no Amazonas. Dados epidemiol&#243;gicos e financeiros das a&#231;&#245;es de combate &#224; COVID-19. Publica&#231;&#245;es</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.fvs.am.gov.br/publicacoes" id="interrefs50">http://www.fvs.am.gov.br/publicacoes</ext-link></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="other" id="sbref60"><person-group person-group-type="author"><collab>Prefeitura de Manaus</collab></person-group><article-title>Publica&#231;&#245;es. COVID-19</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.manaus.am.gov.br/noticia/" id="interrefs60">http://www.manaus.am.gov.br/noticia/</ext-link></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="other" id="sbref70"><person-group person-group-type="author"><collab>Funda&#231;&#227;o de Vigil&#226;ncia em Sa&#250;de do Amazonas</collab></person-group><article-title>Index of media publicacao</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.fvs.am.gov.br/media/publicacao" id="interrefs70">http://www.fvs.am.gov.br/media/publicacao</ext-link></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="book" id="sbref80"><person-group person-group-type="author"><collab>Marcelo Oliveira capyvara</collab></person-group><part-title>Popular repositories</part-title><year>2021</year><publisher-name>GitHub</publisher-name><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://github.com/capyvara" id="interrefs80">https://github.com/capyvara</ext-link></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="other" id="sbref90"><person-group person-group-type="author"><name name-style="western"><surname>Nelson</surname><given-names>BW</given-names></name><collab>Instituto Nacional de Pesquisas da Amaz&#244;nia (INPA)</collab></person-group><article-title>Excess deaths Manaus</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://t.co/6g4HHEAuNY" id="interrefs90">https://t.co/6g4HHEAuNY</ext-link><year>2021</year></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sbref100"><person-group person-group-type="author"><name name-style="western"><surname>Parag</surname><given-names>KV</given-names></name><name name-style="western"><surname>Cowling</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Donnelly</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Deciphering early-warning signals of the elimination and resurgence potential of SARS-CoV-2 from limited data at multiple scales</article-title><source>MedRxiv</source><year>2020</year><comment>published online Jan 5.</comment><pub-id pub-id-type="doi">10.1101/2020.11.23.20236968</pub-id><comment>(preprint)</comment><pub-id pub-id-type="pmcid">PMC8672070</pub-id><pub-id pub-id-type="pmid">34905965</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sbref110"><person-group person-group-type="author"><name name-style="western"><surname>Tassila</surname><given-names>S</given-names></name><name name-style="western"><surname>Pybus</surname><given-names>O</given-names></name><name name-style="western"><surname>Fran&#231;a</surname><given-names>R</given-names></name><etal/></person-group><article-title>Coronavirus prevalence in Brazilian Amazon and Sao Paulo city [data set]</article-title><source>Dryad</source><year>2020</year><comment>published online Dec 8.</comment><pub-id pub-id-type="doi">10.5061/dryad.c59zw3r5n</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sbref120"><person-group person-group-type="author"><name name-style="western"><surname>Dan</surname><given-names>JM</given-names></name><name name-style="western"><surname>Mateu</surname><given-names>J</given-names></name><name name-style="western"><surname>Kato</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection</article-title><source>Science</source><year>2021</year><comment>published online Jan 6.</comment><pub-id pub-id-type="doi">10.1126/science.abf4063</pub-id><pub-id pub-id-type="pmcid">PMC7919858</pub-id><pub-id pub-id-type="pmid">33408181</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sbref130"><person-group person-group-type="author"><name name-style="western"><surname>Lumley</surname><given-names>SF</given-names></name><name name-style="western"><surname>O'Donnell</surname><given-names>D</given-names></name><name name-style="western"><surname>Stoesser</surname><given-names>NE</given-names></name><etal/></person-group><article-title>Antibody status and incidence of SARS-CoV-2 infection in health care workers</article-title><source>N Engl J Med</source><year>2020</year><comment>published online Dec 23.</comment><pub-id pub-id-type="doi">10.1056/NEJMoa2034545</pub-id><pub-id pub-id-type="pmcid">PMC7781098</pub-id><pub-id pub-id-type="pmid">33369366</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="other" id="sbref140"><person-group person-group-type="author"><collab>ODS Atlas Amazonas</collab></person-group><article-title>Inloco. &#205;ndice de Isolamento Social das cidades do Amazonas. Dados cedidos pela empresa Inloco</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://datastudio.google.com/s/o1rTqejYd_4" id="interrefs140">https://datastudio.google.com/s/o1rTqejYd_4</ext-link></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sbref150"><person-group person-group-type="author"><name name-style="western"><surname>Greaney</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Loes</surname><given-names>AN</given-names></name><name name-style="western"><surname>Crawford</surname><given-names>KHD</given-names></name><etal/></person-group><article-title>Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies</article-title><source>BioRxiv</source><year>2021</year><comment>published online Jan 4.</comment><pub-id pub-id-type="doi">10.1101/2020.12.31.425021</pub-id><comment>(preprint)</comment><pub-id pub-id-type="pmcid">PMC7869748</pub-id><pub-id pub-id-type="pmid">33592168</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="other" id="sbref160"><person-group person-group-type="author"><name name-style="western"><surname>Faria</surname><given-names>NR</given-names></name><name name-style="western"><surname>Claro</surname><given-names>IM</given-names></name><name name-style="western"><surname>Candido</surname><given-names>D</given-names></name><etal/></person-group><article-title>Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings. Virological</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586" id="interrefs160">https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586</ext-link><year>January, 2021</year></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="other" id="sbref170"><person-group person-group-type="author"><name name-style="western"><surname>Rambaut</surname><given-names>A</given-names></name><name name-style="western"><surname>Loman</surname><given-names>N</given-names></name><name name-style="western"><surname>Pybus</surname><given-names>OG</given-names></name><etal/></person-group><article-title>Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Virological</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563" id="interrefs170">https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563</ext-link><year>December, 2020</year></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sbref180"><person-group person-group-type="author"><name name-style="western"><surname>Tegally</surname><given-names>H</given-names></name><name name-style="western"><surname>Wilkinson</surname><given-names>E</given-names></name><name name-style="western"><surname>Giovanetti</surname><given-names>M</given-names></name><etal/></person-group><article-title>Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa</article-title><source>MedRxiv</source><year>2020</year><comment>published online Dec 22.</comment><pub-id pub-id-type="doi">10.1101/2020.12.21.20248640</pub-id><comment>(preprint)</comment></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="other" id="sbref190"><person-group person-group-type="author"><name name-style="western"><surname>Naveca</surname><given-names>F</given-names></name><name name-style="western"><surname>da Costa</surname><given-names>C</given-names></name><name name-style="western"><surname>Nascimento</surname><given-names>V</given-names></name><etal/></person-group><article-title>SARS-CoV-2 reinfection by the new variant of concern (VOC) P.1 in Amazonas, Brazil. Virological</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://virological.org/t/sars-cov-2-reinfection-by-the-new-variant-of-concern-voc-p-1-in-amazonas-brazil/596" id="interrefs190">https://virological.org/t/sars-cov-2-reinfection-by-the-new-variant-of-concern-voc-p-1-in-amazonas-brazil/596</ext-link><year>Jan 18, 2021</year></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="other" id="sbref200"><person-group person-group-type="author"><name name-style="western"><surname>Naveca</surname><given-names>F</given-names></name><name name-style="western"><surname>Nascimento</surname><given-names>V</given-names></name><name name-style="western"><surname>Souza</surname><given-names>V</given-names></name><etal/></person-group><article-title>Phylogenetic relationship of SARS-CoV-2 sequences from Amazonas with emerging Brazilian variants harboring mutations E484K and N501Y in the Spike protein. Virological</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://virological.org/t/phylogenetic-relationship-of-sars-cov-2-sequences-from-amazonas-with-emerging-brazilian-variants-harboring-mutations-e484k-and-n501y-in-the-spike-protein/585" id="interrefs200">https://virological.org/t/phylogenetic-relationship-of-sars-cov-2-sequences-from-amazonas-with-emerging-brazilian-variants-harboring-mutations-e484k-and-n501y-in-the-spike-protein/585</ext-link><year>Jan 11, 2021</year></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sbref210"><person-group person-group-type="author"><name name-style="western"><surname>Nonaka</surname><given-names>VCK</given-names></name><name name-style="western"><surname>Franco</surname><given-names>MM</given-names></name><name name-style="western"><surname>Gr&#228;f</surname><given-names>T</given-names></name><etal/></person-group><article-title>Genomic evidence of a SARS-Cov-2 reinfection case with E484K spike mutation in Brazil</article-title><source>Preprints</source><year>2021</year><comment>published online Jan 6.</comment><pub-id pub-id-type="doi">10.20944/preprints202101.0132.v1</pub-id><comment>(preprint)</comment><pub-id pub-id-type="pmcid">PMC8084516</pub-id><pub-id pub-id-type="pmid">33605869</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="other" id="sbref220"><person-group person-group-type="author"><name name-style="western"><surname>Resende</surname><given-names>PC</given-names></name><name name-style="western"><surname>Bezerra</surname><given-names>JF</given-names></name><name name-style="western"><surname>Vasconcelos</surname><given-names>RHT</given-names></name><etal/></person-group><article-title>Spike E484K mutation in the first SARS-CoV-2 reinfection case confirmed in Brazil, 2020. Virological</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://virological.org/t/spike-e484k-mutation-in-the-first-sars-cov-2-reinfection-case-confirmed-in-brazil-2020/584" id="interrefs220">https://virological.org/t/spike-e484k-mutation-in-the-first-sars-cov-2-reinfection-case-confirmed-in-brazil-2020/584</ext-link><year>Jan 10, 2021</year></element-citation></ref></ref-list><ack><p>NRF reports funding from Wellcome Trust, the Royal Society, and the UK Medical Research Council. CAP reports grants from Coordena&#231;&#227;o de Aperfei&#231;oamento de Pessoal de N&#237;vel Superior Brasil and FAPESP. NMF reports grants from the UK Medical Research Council, the UK National Institute of Health Research, Community Jameel, NIH NIGMS, Janssen Pharmaceuticals, the Bill &amp; Melinda Gates Foundation, and Gavi, the Vaccine Alliance. The other authors declare no competing interests.</p></ack></back></article></pmc-articleset>
